Evidence map›Paper›PMID 35601034›Full record

ArticleHealth science reports2022

Predictors of mortality and morbidity in critically ill COVID-19 patients: An experience from a low mortality country.

Mohamad Y Khatib, Dore C Ananthegowda, Moustafa S Elshafei, Hani El-Zeer, Wael I Abdaljawad, Muhsen A Shaheen, Abdulsalam S Ibrahim, Ahmad A Abujaber, Ahmed A Soliman, Ahmed S Mohamed and 7 more

Abstract read
In one paragraph

Article in Health science reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mohamad Y KhatibDepartment of Medicine, Division of Critical Care Hazm Mebaireek General Hospital, Hamad Medical Corporation Doha Qatar.
Dore C AnanthegowdaDepartment of Medicine, Division of Critical Care Hazm Mebaireek General Hospital, Hamad Medical Corporation Doha Qatar.ORCID 0000-0001-7408-5746
Moustafa S ElshafeiDepartment of Medicine, Division of Critical Care Hazm Mebaireek General Hospital, Hamad Medical Corporation Doha Qatar.
Hani El-ZeerDepartment of Medicine, Division of Critical Care Hazm Mebaireek General Hospital, Hamad Medical Corporation Doha Qatar.
Wael I AbdaljawadDepartment of Medicine, Division of Critical Care Hamad General Hospital, Hamad Medical Corporation Doha Qatar.
Muhsen A ShaheenDepartment of Medicine, Division of Critical Care Hamad General Hospital, Hamad Medical Corporation Doha Qatar.
Abdulsalam S IbrahimDepartment of Medicine, Division of Critical Care Hamad General Hospital, Hamad Medical Corporation Doha Qatar.
Ahmad A AbujaberDivision of Critical Care Nursing Hazm Mebaireek General Hospital, Hamad Medical Corporation Doha Qatar.ORCID 0000-0002-8704-4991
Ahmed A SolimanDivision of Critical Care Nursing Hazm Mebaireek General Hospital, Hamad Medical Corporation Doha Qatar.ORCID 0000-0002-2107-5357
Ahmed S MohamedDivision of Critical Care Nursing Hazm Mebaireek General Hospital, Hamad Medical Corporation Doha Qatar.
Mohammad Al-WraidatDepartment of Medicine, Division of Critical Care Hazm Mebaireek General Hospital, Hamad Medical Corporation Doha Qatar.ORCID 0000-0002-5855-8133
Amna AhmedDepartment of Medicine, Division of Critical Care Hazm Mebaireek General Hospital, Hamad Medical Corporation Doha Qatar.
Abdulqadir J NashwanDivision of Critical Care Nursing Hazm Mebaireek General Hospital, Hamad Medical Corporation Doha Qatar.ORCID 0000-0003-4845-4119
Mohamed O SaadPharmacy Department Al Wakra Hospital, Hamad Medical Corporation Doha Qatar.ORCID 0000-0002-2221-4216
Adeel A ButtDepartment of Medicine Hamad Medical Corporation Doha Qatar.ORCID 0000-0002-1118-1826
Muna A Al-MaslamaniDepartment of Infectious Disease Communicable Diseases Centre, Hamad Medical Corporation Doha Qatar.
Ahmed Al-MohammedDepartment of Medicine, Division of Critical Care Hamad General Hospital, Hamad Medical Corporation Doha Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Clinical characteristics and factors associated with mortality in patients admitted to the intensive care unit (ICU) in countries with low case fatality rates (CFR) are unknown. We sought to determine these in a large cohort of critically ill COVID-19 patients in Qatar and explore the early mortality predictors. Methods: We retrospectively studied the clinical characteristics and outcomes in patients admitted to the ICU at the national referral hospital for COVID-19 patients in Qatar. Logistic regression analysis was used to determine factors associated with mortality. Results: Between March 7 and July 16, 2020, a total of 1079 patients with COVID-19 were admitted to the ICU. The median (IQR) age of patients was 50 (41-59) years. Diabetes (47.3%) and hypertension (42.6%) were the most common comorbidities. In-hospital mortality was 12.6% overall and 25.9% among those requiring mechanical ventilation. Factors independently associated with mortality included older age ([OR]; 2.3 [95% CI; 1.92-2.75] for each 10-year increase in age, Conclusions: The mortality rate among critically ill COVID-19 patients is low in Qatar compared to other countries. Older age, chronic kidney disease, active malignancy, higher neutrophil-to-lymphocyte ratios, lower platelet counts, higher serum ferritin levels, and higher serum bilirubin levels are independent predictors of in-hospital mortality.

Indexed as

ARDSCOVID‐19intensive caremortalityQatarSARS‐CoV‐2

Identifiers

PMID35601034
PMCPMC9111769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.